source Post navigation Mozart Therapeutics Announces Oral Presentation on MTX-101 at the 2024 American Diabetes Association's 84th … – StreetInsider.com Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes … – StockTitan